Watch Demo

Particle Therapy Market Research Report by Therapy Type, Component, Cancer Type, End-User, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030

Particle Therapy Market Research Report by Therapy Type, Component, Cancer Type, End-User, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030
  • Publish Date:January 2023

  • Number of Pages:150

  • Report ID:6403635

  • Format:PDF

  • Publisher:360iResearch

$ 3949

Summary

Particle Therapy Market Research Report by Therapy Type (Fast-Neutron Therapy, Heavy Ion Therapy, and Proton Therapy), Component, Cancer Type, End-User, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030

The United States Particle Therapy Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Particle Therapy Market.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the United States Particle Therapy Market.

Cumulative Impact of Russia-Ukraine Conflict:

We continuously monitor and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the United States Particle Therapy Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The United States Particle Therapy Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the United States Particle Therapy Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group’s economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players’ strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the United States Particle Therapy Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Therapy Type, the market is studied across Fast-Neutron Therapy, Heavy Ion Therapy, and Proton Therapy.

Based on Component, the market is studied across Products and Systems. The Products is further studied across Cyclotrons, Synchrocyclotrons, and Synchrotrons. The Systems is further studied across Multi-Room Systems and Single-Room Systems.

Based on Cancer Type, the market is studied across Breast Cancer, Head & Neck Cancer, Lung Cancer, Pediatric Cancer, and Prostate Cancer.

Based on End-User, the market is studied across Ambulatory Surgery Centers and Hospitals & Clinics.

Based on State, the market is studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the United States Particle Therapy Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The United States Particle Therapy Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The United States Particle Therapy Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The United States Particle Therapy Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Particle Therapy Market, including Advanced Oncotherapy plc, Danfysik A/S, Elekta AB, Hitachi, Ltd., IBA International, Koninklijke Philips N.V., Mevion Medical Systems, Mitsubishi Electric Corporation, Optivus Proton Therapy, Inc., ProTom International, Provision Healthcare, LLC, PTW Freiburg GmbH, SAH Global LLC, Sumitomo Heavy Industries, Ltd., Toshiba Medical Systems Corporation, and Varian Medical Systems, Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Particle Therapy Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Particle Therapy Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Particle Therapy Market?
4. What is the competitive strategic window for opportunities in the United States Particle Therapy Market?
5. What are the technology trends and regulatory frameworks in the United States Particle Therapy Market?
6. What is the market share of the leading vendors in the United States Particle Therapy Market?
7. What modes and strategic moves are considered suitable for entering the United States Particle Therapy Market?

Table of contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in number of cancer patients along with rise in geriatric population in the U.S
5.1.1.2. Growing clinical trial activities in the United States
5.1.2. Restraints
5.1.2.1. High cost associated with particle therapy treatment
5.1.3. Opportunities
5.1.3.1. New developments in treatment planning and verification of particle beam therapy
5.1.3.2. Emerging research activities for particle therapy
5.1.4. Challenges
5.1.4.1. Limited insurance coverage for particle therapy
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Particle Therapy Market, by Therapy Type
6.1. Introduction
6.2. Fast-Neutron Therapy
6.3. Heavy Ion Therapy
6.4. Proton Therapy

7. Particle Therapy Market, by Component
7.1. Introduction
7.2. Products
7.3.1. Cyclotrons
7.3.2. Synchrocyclotrons
7.3.3. Synchrotrons
7.3. Systems
7.4.1. Multi-Room Systems
7.4.2. Single-Room Systems

8. Particle Therapy Market, by Cancer Type
8.1. Introduction
8.2. Breast Cancer
8.3. Head & Neck Cancer
8.4. Lung Cancer
8.5. Pediatric Cancer
8.6. Prostate Cancer

9. Particle Therapy Market, by End-User
9.1. Introduction
9.2. Ambulatory Surgery Centers
9.3. Hospitals & Clinics

10. California Particle Therapy Market
10.1. Introduction

11. Florida Particle Therapy Market
11.1. Introduction

12. Illinois Particle Therapy Market
12.1. Introduction

13. New York Particle Therapy Market
13.1. Introduction

14. Ohio Particle Therapy Market
14.1. Introduction

15. Pennsylvania Particle Therapy Market
15.1. Introduction

16. Texas Particle Therapy Market
16.1. Introduction

17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis, By Key Player
17.3. Market Share Analysis, By Key Player
17.4. Product Portfolio Analysis, By Key Player
17.5. Competitive Scenario
17.5.1. Merger & Acquisition
17.5.2. Agreement, Collaboration, & Partnership
17.5.3. New Product Launch & Enhancement
17.5.4. Investment & Funding
17.5.5. Award, Recognition, & Expansion

18. Company Usability Profiles
18.1. Advanced Oncotherapy plc
18.2. Danfysik A/S
18.3. Elekta AB
18.4. Hitachi, Ltd.
18.5. IBA International
18.6. Koninklijke Philips N.V.
18.7. Mevion Medical Systems
18.8. Mitsubishi Electric Corporation
18.9. Optivus Proton Therapy, Inc.
18.10. ProTom International
18.11. Provision Healthcare, LLC
18.12. PTW Freiburg GmbH
18.13. SAH Global LLC
18.14. Sumitomo Heavy Industries, Ltd.
18.15. Toshiba Medical Systems Corporation
18.16. Varian Medical Systems, Inc.

19. Appendix
19.1. Discussion Guide
19.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES PARTICLE THERAPY MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES PARTICLE THERAPY MARKET SIZE, 2022 VS 2030
FIGURE 3. UNITED STATES PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 5. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. UNITED STATES PARTICLE THERAPY MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 7. UNITED STATES PARTICLE THERAPY MARKET DYNAMICS
FIGURE 8. UNITED STATES PARTICLE THERAPY MARKET PORTER'S FIVE FORCES ANALYSIS
FIGURE 9. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2022 VS 2030 (%)
FIGURE 10. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. UNITED STATES PARTICLE THERAPY MARKET COMPETITIVE STRATEGIC WINDOW, BY THERAPY TYPE, 2030
FIGURE 12. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY FAST-NEUTRON THERAPY, 2018-2030 (USD MILLION)
FIGURE 13. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY HEAVY ION THERAPY, 2018-2030 (USD MILLION)
FIGURE 14. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
FIGURE 15. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2022 VS 2030 (%)
FIGURE 16. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PARTICLE THERAPY MARKET COMPETITIVE STRATEGIC WINDOW, BY COMPONENT, 2030
FIGURE 18. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
FIGURE 19. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY CYCLOTRONS, 2018-2030 (USD MILLION)
FIGURE 20. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY SYNCHROCYCLOTRONS, 2018-2030 (USD MILLION)
FIGURE 21. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY SYNCHROTRONS, 2018-2030 (USD MILLION)
FIGURE 22. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
FIGURE 23. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY MULTI-ROOM SYSTEMS, 2018-2030 (USD MILLION)
FIGURE 24. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY SINGLE-ROOM SYSTEMS, 2018-2030 (USD MILLION)
FIGURE 25. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2022 VS 2030 (%)
FIGURE 26. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 27. UNITED STATES PARTICLE THERAPY MARKET COMPETITIVE STRATEGIC WINDOW, BY CANCER TYPE, 2030
FIGURE 28. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
FIGURE 29. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY HEAD & NECK CANCER, 2018-2030 (USD MILLION)
FIGURE 30. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY LUNG CANCER, 2018-2030 (USD MILLION)
FIGURE 31. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY PEDIATRIC CANCER, 2018-2030 (USD MILLION)
FIGURE 32. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY PROSTATE CANCER, 2018-2030 (USD MILLION)
FIGURE 33. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 34. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 35. UNITED STATES PARTICLE THERAPY MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2030
FIGURE 36. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
FIGURE 37. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
FIGURE 38. CALIFORNIA PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 39. FLORIDA PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 40. ILLINOIS PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 41. NEW YORK PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 42. OHIO PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 43. PENNSYLVANIA PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 44. TEXAS PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 45. UNITED STATES PARTICLE THERAPY MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 46. UNITED STATES PARTICLE THERAPY MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 47. UNITED STATES PARTICLE THERAPY MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022

List of Tables

TABLE 1. UNITED STATES PARTICLE THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. UNITED STATES PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 5. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 6. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY FAST-NEUTRON THERAPY, 2018-2030 (USD MILLION)
TABLE 7. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY FAST-NEUTRON THERAPY, BY STATE, 2018-2030 (USD MILLION)
TABLE 8. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY HEAVY ION THERAPY, 2018-2030 (USD MILLION)
TABLE 9. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY HEAVY ION THERAPY, BY STATE, 2018-2030 (USD MILLION)
TABLE 10. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
TABLE 11. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY PROTON THERAPY, BY STATE, 2018-2030 (USD MILLION)
TABLE 12. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 13. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 14. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, BY STATE, 2018-2030 (USD MILLION)
TABLE 15. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY CYCLOTRONS, 2018-2030 (USD MILLION)
TABLE 16. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY CYCLOTRONS, BY STATE, 2018-2030 (USD MILLION)
TABLE 17. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY SYNCHROCYCLOTRONS, 2018-2030 (USD MILLION)
TABLE 18. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY SYNCHROCYCLOTRONS, BY STATE, 2018-2030 (USD MILLION)
TABLE 19. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY SYNCHROTRONS, 2018-2030 (USD MILLION)
TABLE 20. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY SYNCHROTRONS, BY STATE, 2018-2030 (USD MILLION)
TABLE 21. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 22. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, BY STATE, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY MULTI-ROOM SYSTEMS, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY MULTI-ROOM SYSTEMS, BY STATE, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY SINGLE-ROOM SYSTEMS, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY SINGLE-ROOM SYSTEMS, BY STATE, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY BREAST CANCER, BY STATE, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY HEAD & NECK CANCER, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY HEAD & NECK CANCER, BY STATE, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY LUNG CANCER, BY STATE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY PEDIATRIC CANCER, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY PEDIATRIC CANCER, BY STATE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY PROSTATE CANCER, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY PROSTATE CANCER, BY STATE, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY STATE, 2018-2030 (USD MILLION)
TABLE 43. CALIFORNIA PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 44. CALIFORNIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 45. CALIFORNIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 46. CALIFORNIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 47. CALIFORNIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. FLORIDA PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 49. FLORIDA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 50. FLORIDA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 51. FLORIDA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 52. FLORIDA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. ILLINOIS PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 54. ILLINOIS PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 55. ILLINOIS PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 56. ILLINOIS PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 57. ILLINOIS PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. NEW YORK PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 59. NEW YORK PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 60. NEW YORK PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 61. NEW YORK PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 62. NEW YORK PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. OHIO PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 64. OHIO PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 65. OHIO PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 66. OHIO PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 67. OHIO PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. PENNSYLVANIA PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 69. PENNSYLVANIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 70. PENNSYLVANIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 71. PENNSYLVANIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 72. PENNSYLVANIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. TEXAS PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 74. TEXAS PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 75. TEXAS PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 76. TEXAS PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 77. TEXAS PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES PARTICLE THERAPY MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 79. UNITED STATES PARTICLE THERAPY MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 80. UNITED STATES PARTICLE THERAPY MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 81. UNITED STATES PARTICLE THERAPY MARKET RANKING, BY KEY PLAYER, 2022
TABLE 82. UNITED STATES PARTICLE THERAPY MARKET SHARE, BY KEY PLAYER, 2022
TABLE 83. UNITED STATES PARTICLE THERAPY MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 84. UNITED STATES PARTICLE THERAPY MARKET MERGER & ACQUISITION
TABLE 85. UNITED STATES PARTICLE THERAPY MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 86. UNITED STATES PARTICLE THERAPY MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 87. UNITED STATES PARTICLE THERAPY MARKET INVESTMENT & FUNDING
TABLE 88. UNITED STATES PARTICLE THERAPY MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 89. UNITED STATES PARTICLE THERAPY MARKET: LICENSE & PRICING

Companies Mentioned

Advanced Oncotherapy plc
Danfysik A/S
Elekta AB
Hitachi, Ltd.
IBA International
Koninklijke Philips N.V.
Mevion Medical Systems
Mitsubishi Electric Corporation
Optivus Proton Therapy, Inc.
ProTom International
Provision Healthcare, LLC
PTW Freiburg GmbH
SAH Global LLC
Sumitomo Heavy Industries, Ltd.
Toshiba Medical Systems Corporation
Varian Medical Systems, Inc.

Methodology

Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.

The data is gathered from a wide range of sources, including industry reports, government statistics, and company financials. This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary interviews are conducted with industry experts and key stakeholders to gather their insights and perspectives on the market. This information is then combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis is also carried out to understand the impact of external factors on the market. Finally, country-level data analysis is performed to understand the market dynamics in specific regions and countries.

Reportlinker's market research methodology is designed to provide clients with a clear understanding of the market, its trends, and its future potential.